Mr. Am Gill reports

BIOSENTA ANNOUNCES PRIVATE PLACEMENT FINANCING

Biosenta Inc. has arranged a non-brokered private placement financing of 1.25 million units of the company for aggregate gross proceeds of $500,000.

Each unit will consist of one common share in the capital of the company and one-half of common share purchase warrant. Each warrant will entitle the holder thereof to acquire, subject to adjustment in certain events, one common share in the capital of the company at an exercise price of 80 cents for a period of 18 months from the closing date of the offering.

The company intends to use the net proceeds of the offering for general corporate purposes.

The closing of the offering is expected to occur on or about Dec. 22, 2023, or such other date or dates as the company may determine.

The securities issued pursuant to the offering shall be subject to a four-month-plus-one-day hold period from the closing date in accordance with applicable Canadian securities laws.

About Biosenta Inc.

Biosenta is a Canadian-based company that develops and manufactures a range of safe and environmentally sound chemical compounds for household and industrial applications.

We seek Safe Harbor.